Durable

Choose a stent with sustained results through 5 years

Selecting a treatment device is an important decision for each patient. In 5-year trials, approximately 80% of patients survive to this timepoint,¹ which demands a device that can sustain its performance long-term.

Zilver PTX has repeatedly achieved long-term success, out to 5 years, and sustained durability^2,3,4 with consistently low fracture rates in randomized trials.^2,5 When placing a drug-eluting stent, you can feel confident Zilver PTX will meet the long-term needs of your patient.

The Zilver PTX RCT²

The IMPERIAL RCT 12-month fracture rates⁵

1. Parikh SA, Schneider PA, Mullin CM, et al. Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis. Lancet. 2023;402(10415):1848–1856. doi: 10.1016/S0140-6736(23)02189-X. Epub 2023 Oct 24. PMID: 37890499.
2. Dake MD, Ansel GM, Jaff MR, et al. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation. 2016;133(15):1472-1483.
3. Sugimoto M, Komori K, Yokoi H, et al. Long-term effectiveness of a drug-eluting stent for femoropopliteal in-stent restenosis: sub-analysis of the Zilver PTX Japan post-market surveillance study. J Endovasc Ther. 2021;28:229-235. doi: 10.1177/1526602820966708.
4. Bosiers MJ, De Donato G, Torsello G, et al. ZILVERPASS Study: Zilver PTX stent versus prosthetic above-the-knee bypass surgery in femoropopliteal lesions. 5-year results. Cardiovasc Intervent Radiol. 2024;46(10):1348–1358. doi.org/10.1007/s00270-023-03549-0
5. Gray WA, Keirse K, Soga Y, et al.; IMPERIAL investigators. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet. 2018;392(10157):1541–1551. doi: 10.1016/S0140-6736(18)32262-1. Epub 2018 Sep 24. PMID: 30262332.